Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00471614 · ClinicalTrials.gov registry record · Phase 2
Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00471614: Completed Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00471614 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00471614, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether uridine supplementation will improve insulin sensitivity and overall carbohydrate metabolism in HIV-positive subjects who are currently undergoing treatment with antiretroviral regimens containing stavudine or zidovudine and who have evidence of impaired mitochondrial function and insulin resistance.
Interventions
- DRUG NucleomaxX (contains uridine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2007-04 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
What the finished NCT00471614 record still lists
NCT00471614 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which NucleomaxX (contains uridine) is the first listed.
NCT00471614 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00471614 about?
NCT00471614 is a clinical study titled "Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine". The purpose of this study is to determine whether uridine supplementation will improve insulin sensitivity and overall carbohydrate metabolism in HIV-positive subjects who are currently undergoing treatment with antiretroviral regimens containing stavudine or zidovudine and who have evidence of impa...
What is the current status of trial NCT00471614?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2007-04. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00471614?
The interventions under investigation include: NucleomaxX (contains uridine) (DRUG).
Who is sponsoring clinical trial NCT00471614?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00471614's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia